Showing 1 - 7 results of 7 for search 'Anna Fogdell‐Hahn', query time: 0.04s
Refine Results
-
1
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity by Francesca Faustini, Francesca Faustini, Natalie Sippl, Natalie Sippl, Ragnhild Stålesen, Ragnhild Stålesen, Karine Chemin, Karine Chemin, Nicky Dunn, Nicky Dunn, Anna Fogdell-Hahn, Anna Fogdell-Hahn, Iva Gunnarsson, Vivianne Malmström, Vivianne Malmström
Published 2022-04-01
Article -
2
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment by Clemens Warnke, Tomas Olsson, Ingrid Kockum, Tomas Bergström, Anna Fogdell-Hahn, Linn Persson Berg, Marcus Eriksson, Sonia Longhi, Elisabeth Thomsson, Malin Bäckström
Published 2022-07-01
Article -
3
Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ by Kirsty E. Waddington, Kirsty E. Waddington, Artemis Papadaki, Leda Coelewij, Leda Coelewij, Marsilio Adriani, Petra Nytrova, Eva Kubala Havrdova, Anna Fogdell-Hahn, Rachel Farrell, Pierre Dönnes, Pierre Dönnes, Inés Pineda-Torra, Elizabeth C. Jury
Published 2020-07-01
Article -
4
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants. by Emilie Sundqvist, Dorothea Buck, Clemens Warnke, Eva Albrecht, Christian Gieger, Mohsen Khademi, Izaura Lima Bomfim, Anna Fogdell-Hahn, Jenny Link, Lars Alfredsson, Helle Bach Søndergaard, Jan Hillert, International Multiple Sclerosis Genetics Consortium, Annette B Oturai, Bernhard Hemmer, Ingrid Kockum, Tomas Olsson
Published 2014-04-01
Article -
5
COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls by Elisa Longinetti, Hannah Bower, Kyla A McKay, Simon Englund, Joachim Burman, Katharina Fink, Anna Fogdell‐Hahn, Martin Gunnarsson, Jan Hillert, Annette Langer‐Gould, Jan Lycke, Petra Nilsson, Jonatan Salzer, Anders Svenningsson, Johan Mellergård, Tomas Olsson, Fredrik Piehl, Thomas Frisell
Published 2022-09-01
Article -
6
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis by Elin Engdahl, Elin Engdahl, Rasmus Gustafsson, Rasmus Gustafsson, Jesse Huang, Jesse Huang, Martin Biström, Izaura Lima Bomfim, Izaura Lima Bomfim, Pernilla Stridh, Pernilla Stridh, Mohsen Khademi, Mohsen Khademi, Nicole Brenner, Julia Butt, Angelika Michel, Daniel Jons, Maria Hortlund, Lucia Alonso-Magdalena, Anna Karin Hedström, Anna Karin Hedström, Anna Karin Hedström, Louis Flamand, Masaru Ihira, Tetsushi Yoshikawa, Oluf Andersen, Jan Hillert, Jan Hillert, Lars Alfredsson, Lars Alfredsson, Tim Waterboer, Peter Sundström, Tomas Olsson, Tomas Olsson, Ingrid Kockum, Ingrid Kockum, Anna Fogdell-Hahn, Anna Fogdell-Hahn
Published 2019-11-01
Article -
7
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results. by Jenny Link, Ryan Ramanujam, Michael Auer, Malin Ryner, Signe Hässler, Delphine Bachelet, Cyprien Mbogning, Clemens Warnke, Dorothea Buck, Poul Erik Hyldgaard Jensen, Claudia Sievers, Kathleen Ingenhoven, Nicolas Fissolo, Raija Lindberg, Verena Grummel, Naoimh Donnellan, Manuel Comabella, Xavier Montalban, Bernd Kieseier, Per Soelberg Sørensen, Hans-Peter Hartung, Tobias Derfuss, Andy Lawton, Dan Sikkema, Marc Pallardy, Bernhard Hemmer, Florian Deisenhammer, Philippe Broët, Pierre Dönnes, Julie Davidson, Anna Fogdell-Hahn, ABIRISK Consortium
Published 2017-01-01
Article